AZD4017
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for AZD4017, covering 2009-06-16 to 2021-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. [Phase 2]